Alzheimer's disease (AD) is the leading cause of dementia, presenting a significant unmet
medical need worldwide. The pathogenesis of AD involves various pathophysiological …

Alzheimer's disease (AD) is the most common cause of memory impairment and dementia in
the elderly. AD is pathologically characterized by extracellular deposits of beta-amyloid (Aβ) …

Alzheimer's disease (AD) is the most common cause of dementia. It is characterized by
cognitive decline and progressive memory loss. The aim of this review was to update the …

Despite presence of substantial evidence suggesting the pivotal role of amyloid (Aβ) in
Alzheimer's disease (AD), very few therapeutic agents have been able to ameliorate the …

Introduction: Alzheimer's disease (AD) is the most important neurodegenerative disorder
with a global cost worldwide of over $700 billion. Pharmacological treatment accounts for 10 …

Alzheimer's disease (AD) is the most common cause of dementia associated with a
progressive neurodegenerative disorder, with a prevalence of 44 million people throughout …

Alzheimer's disease (AD) is an age-related neurodegenerative disorder characterized by
progressive deterioration of cognitive functions. The pathological hallmarks are extracellular …

Alzheimer's disease (AD) and dementia are disorders of the aging population and becoming
major health care burden worldwide due to unavailability of complete therapy. AD is the …

Alzheimer's Disease (AD) remains one of the most challenging health-related issues for our
society. It is becoming increasingly prevalent, especially in developed countries, due to the …